RARE
NASDAQStockUltragenyx Pharmaceutical Inc.
$21.86-0.36 (-1.62%)
52-Week Range
$19.72
$41.44
Key Stats
Market Cap
2.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.21
Volume
1.0M
Avg Volume
1.9M
Performance
1M
-9.09%
3M
-40.08%
6M
-25.14%
YTD
-8.01%
1Y
-44.69%
3Y
-46.47%
5Y
-83.21%
Price Chart
ETF Exposure
RARE is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WSML | iShares MSCI World Small-Cap ETF | 0.02% |
| BALI | iShares U.S. Large Cap Premium Income Active ETF | 0.02% |
| IWR | iShares Russell Mid-Cap ETF | 0.02% |
| REMC | Columbia Research Enhanced Mid Cap ETF | 0.02% |
| ENHU | iShares Enhanced Large Cap Core Active ETF | 0.01% |
| GGUS | Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| IWF | iShares Russell 1000 Growth ETF | 0.01% |
| VONG | Vanguard Russell 1000 Growth ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| VONE | Vanguard Russell 1000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| IWB | iShares Russell 1000 ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| RECS | Columbia Research Enhanced Core ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| CHEP | AGFiQ U.S. Market Neutral Value Fund | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About RARE ETF Exposure
Ultragenyx Pharmaceutical Inc. (RARE) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.1B, RARE is a widely held institutional stock. The stock currently trades at $21.86. Investors can gain exposure to RARE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RARE, sorted by portfolio weight.